COMMUNIQUÉS West-GlobeNewswire

Ossur Hf : Transactions in relation to share buyback program
19/06/2017
Announcement from Össur hf. No. 45/2017 Reykjavík, 19 June 2017 On 1 December 2016, Össur hf. initiated a new share buy-back program, see Company announcement no. 96/2016. The purpose of the share buyback program is to [...]
Helén Tuvesson new CEO of Active Biotech AB from July 1, 2017
19/06/2017
PRESS RELEASE Lund - Active Biotech AB (Nasdaq Stockholm: ACTI) today announces that the Board has appointed the company's current CSO Helén Tuvesson as new CEO of Active Biotech AB. Helén Tuvesson will take up the [...]
Novo Nordisk A/S - Share repurchase programme
19/06/2017
Bagsværd, Denmark, 19 June 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]
Extrodinary General Shareholders' Meeting
19/06/2017
NEWS RELEASE IRVINE, CA, and HERSTAL, BELGIUM - 14:30 CEST, June 19 2017 - MDxHealth SA (Euronext: MDXH.BR) held today its Extraordinary General Shareholders' Meeting in Brussels. The shareholders approved all agenda [...]
Assemblée Générale Extraordinaire des Actionnaires
19/06/2017
COMMUNIQUE DE PRESSE IRVINE, CA, et HERSTAL, BELGIQUE, le 19 juin , 14:30 CEST - MDxHealth SA (Euronext: MDXH.BR) a tenu aujourd'hui son Assemblée Générale Extraordinaire des Actionnaires à Bruxelles. Les actionnaires [...]
Eckert & Ziegler BEBIG: Meeting Minutes Annual General Meeting
19/06/2017
Seneffe, June 19, 2017. The Minutes and all relevant documents regarding the Annual General Meeting 2017 can be downloaded on the website: http://www.bebig.com/home/investors/shareholder_information/ About Eckert & [...]
Eckert & Ziegler BEBIG: Procès verbal de l'assemblée générale des actionnaires
19/06/2017
Seneffe, le 19 juin 2017. Le procès verbal ainsi que tous les documents relatifs à l'Assemblé Générale 2017 peuvent être téléchargés sur le site internet: http://www.bebig.com/home/investors/shareholder_information/ A [...]
Glepaglutide meets primary endpoint in Phase 2 trial in patients with short bowel syndrome
19/06/2017
Glepaglutide* is a novel long-acting GLP-2 analogue Reduction in fecal wet weight output of 30% and 23% in the two highest dose groups Increases in gastrointestinal fluid and energy absorption observed The dose response [...]
187,133 Orion Corporation A shares converted into B shares
19/06/2017
ORION CORPORATION STOCK EXCHANGE RELEASE 19 JUNE 2017 at 10.50 a.m. EEST 187,133 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 187, [...]
Diaxonhit : Nouvelle composition du conseil de surveillance
19/06/2017
Nouvelle composition du conseil de surveillance de DIAXONHIT Jean-Pierre HERMET est nommé président du conseil de surveillance Patrick de ROQUEMAUREL est nommé membre du conseil de surveillance Démissions de Laurent [...]
Sandoz receives approval in Europe for Rixathon® (biosimilar rituximab) to treat blood cancers and immunological diseases
19/06/2017
European Commission approves Sandoz Rixathon ® to treat blood cancers and immunological diseases. Approval expected to broa den patient access to biologics and enable budget-constrained healthcare systems to reallocate [...]
MDxHealth and Queensland University of Technology Collaborate on Oral Cancer Liquid Biopsy Test
19/06/2017
NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, June 19, 2017 - MDxHealth SA (Euronext: MDXH.BR), today announced that it has signed a scientific agreement with [...]
MDxHealth et l'Université de technologie du Queensland collaborent sur un test de biopsie liquide pour le dépistage de cancer buccal
19/06/2017
COMMUNIQUE DE PRESSE / INFORMATION REGLEMENTAIRE / INFORMATION PRIVILEGIEE IRVINE, CA, et HERSTAL, BELGIQUE - 07:00 AM CEST - Le 19 juin 2017 - MDxHealth SA (Euronext: MDXH.BR) a annoncé aujourd'hui qu'il a signé un [...]
Medtronic Exclusive Reactive ATP(TM) Therapy Slows Progression of Atrial Fibrillation in Real-World Patient Population
18/06/2017
Data Presented as Late Breaking Clinical Trial at EUROPACE 2017 DUBLIN and VIENNA - June 18, 2017 - Continuing its leadership in the detection, reduction, and treatment of atrial fibrillation (AF), Medtronic plc (NYSE: [...]
DBV Technologies Highlights Poster Presentations on EPIT® at the 2017 EAACI Congress
17/06/2017
Press Release Montrouge, France, June 17, 2017 DBV Technologies Highlights Poster Presentations on EPIT ® at the 2017 EAACI Congress DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) [...]
DBV Technologies présente des données sur l'immunothérapie épicutanée (EPIT®) au Congrès de l'EAACI 2017
17/06/2017
Communiqué de Presse Montrouge, France, 17 juin 2017, 8h30 CEST DBV Technologies présente des données sur l'immunothérapie épicutanée (EPIT ® ) au Congrès de l'EAACI 2017 DBV Technologies (Euronext : DBV - ISIN : [...]
Novartis International AG: New patient survey highlights need for more action to help severe asthma patients gain control of their disease
17/06/2017
Large-scale European patient survey found that 94% of severe allergic asthma patients were unable to fully control their disease These new data underscore the disconnect between self-perceived control and clinical [...]
GENFIT : RESULTATS DE L'ASSEMBLEE GENERALE ORDINAIRE ET EXTRAORDINAIRE DU 16 JUIN 2017
16/06/2017
GENFIT : resultats de l'ASSEMBLEE GENERALE ORDINAIRE ET EXTRAORDINAIRE DU 16 JUIN 2017 - Approbation du changement du mode d'administration de la Société - Nomination du Président-Directeur Général et des Comités du [...]
GENFIT: OUTCOME OF THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF JUNE 16, 2017
16/06/2017
GENFIT: OUTCOME OF THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF JUNE 16, 2017 - Approval of the change in mode of administration and management of the Company - Nomination of the Chairman and CEO and the [...]

Pages